New spiro[3h-indole-3,2'-pyrrolidin]-2(1h)-one compounds and derivatives as mdm2-p53 inhibitors

Abstract

The present invention encompasses compounds of formula (I) wherein the groups R 1 to R 7 , A, V, W, X, Y, n, r and q are defined in claim 1 , their use as inhibitors of MDM2-p53 interaction, pharmaceutical compositions which contain compounds of this kind, their use as medicaments, especially as agents for treatment and/or prevention of oncological diseases, and synthetic intermediates.

1 . Synthetic intermediate of formula A-4: 
       
         
           
           
               
               
           
         
       
       wherein
 R 2  and R 3 , each independently, is selected from among hydrogen, C 6-10 aryl, 5-10 membered heteroaryl and 3-10 membered heterocyclyl, wherein this C 6-10 aryl, 5-10 membered heteroaryl and 3-10 membered heterocyclyl is optionally substituted by one or more, identical or different R b2  and/or R c2 ;
 each R b2  is independently selected from among —OR c2 , —NR c2 R c2 , halogen, —CN, —C(O)R c2 , —C(O)OR c2 , —C(O)NR c2 R c2 , —S(O) 2 R c2 , —S(O) 2 NR ca R c2 , —NHC(O)R c2  and —N(C 1-4 alkyl)C(O)R c2 ; 
 each R c2  independently of one another denotes hydrogen or a group, optionally substituted by one or more, identical or different R d2  and/or R e2 , selected from among C 1-6 alkyl, C 2-6 alkenyl, C 2-6 alkynyl, C 1-6 haloalkyl, C 3-6 cycloalkyl, C 4-6 cycloalkenyl, C 6-10 aryl, 5-10 membered heteroaryl and 3-10 membered heterocyclyl; 
 each R d2  is independently selected from among —OR e2 , —NR e2 R e2 , halogen, —CN, —C(O)R e2 , —C(O)OR e2 , —C(O)NR e2 R e2 , —S(O) 2 R e2 , —S(O) 2 NR e2 R e2 , —NHC(O)R e2  and —N(C 1-4 alkyl)C(O)R e2 ; 
 each R e2  independently of one another denotes hydrogen or a group selected from among C 1-6 alkyl, C 2-6 alkenyl, C 2-6 alkynyl, C 1-6 haloalkyl, C 3-6 cycloalkyl, C 4-6 cycloalkenyl, C 6-10 aryl, 5-10 membered heteroaryl and 3-10 membered heterocyclyl; 
 
 R 5  and R 6 , each independently, is selected from among hydrogen, C 1-4 alkyl and C 1-4 haloalkyl; 
 n denotes the number 0 or 1; 
 each R 7  is independently selected from among halogen, C 1-4 alkyl, —CN, C 1-4 haloalkyl, —OC 1-4  alkyl and —OC 1-4 haloalkyl; 
 q denotes the number 0, 1, 2 or 3; 
 W, X and Y is each independently selected from —N═ and —CH═ 
 with the proviso that the hydrogen in each —CH═ may be replaced by a substituent R 7  if present and that a maximum of two of W, X and Y can be —N═; 
 V is oxygen or sulfur; 
 or a salt thereof. 
 
     
     
         2 . Synthetic intermediate of formula A-8: 
       
         
           
           
               
               
           
         
       
       wherein
 R 1  is a group, optionally substituted by one or more, identical or different R b1  and/or R c1 , selected from among C 1-6 alkyl, C 2-6  alkenyl, C 2-6  alkynyl, C 1-6 haloalkyl, C 3-7 cycloalkyl, C 4-7  cycloalkenyl, C 6-10 aryl, 5-10 membered heteroaryl and 3-10 membered heterocyclyl;
 each R b1  is independently selected from among —OR c1 , —NR c1 R c1 , halogen, —CN, —C(O)R c1 , —C(O)OR c1 , —C(O)NR c1 R c1 , —S(O) 2 R c1 , —S(O) 2 NR c1 R c1 , —NHC(O)R c1  and —N(C 1-4 alkyl)C(O)R c1 ; 
 each R c1  independently of one another denotes hydrogen or a group, optionally substituted by one or more, identical or different R d1  and/or R e1 , selected from among C 1-6 alkyl, C 2-6 alkenyl, C 2-6 alkynyl, C 1-6 haloalkyl, C 3-7 cycloalkyl, C 4-7 cycloalkenyl, C 6-10 aryl, 5-10 membered heteroaryl and 3-10 membered heterocyclyl; 
 each R d1  is independently selected from among —OR e1 , —NR e1 R e1 , halogen, —CN, —C(O)R e1 , —C(O)OR e1 , —C(O)NR e1 R e1 , —S(O) 2 R e1 , —S(O) 2 NR e1 R e1 , —NHC(O)R e1  and —N(C 1-4 alkyl)C(O)R e1 ; 
 each R e1  independently of one another denotes hydrogen or a group, optionally substituted by one or more, identical or different R f1  and/or R g1 , selected from among C 1-6  alkyl, C 2-6  alkenyl, C 2-6 alkynyl, C 1-6 haloalkyl, C 3-7 cycloalkyl, C 4-7 cycloalkenyl, C 6-10 aryl, 5-10 membered heteroaryl and 3-10 membered heterocyclyl; 
 each R f1  is independently selected from among —OR g1 , —NR g1 R g1 , halogen, —CN, —C(O)R g1 , —C(O)OR g1 , —C(O)NR g1 R g1 , —S(O) 2 R g1 , —S(O) 2 NR g1 R g1 , —NHC(O)R g1  and —N(C 1-4 alkyl)C(O)R g1 ; 
 each R g1  is independently selected from among hydrogen, C 1-6 alkyl, C 2-6 alkenyl, C 2-6 alkynyl, C 1-6 haloalkyl, C 3-7 cycloalkyl, C 4-7 cycloalkenyl, C 6-10 aryl, 5-10 membered heteroaryl and 3-10 membered heterocyclyl; 
 
 R 2  and R 3 , each independently, is selected from among hydrogen, C 6-10 aryl, 5-10 membered heteroaryl and 3-10 membered heterocyclyl, wherein this C 6-10  aryl, 5-10 membered heteroaryl and 3-10 membered heterocyclyl is optionally substituted by one or more, identical or different R b2  and/or R c2 ;
 each R b2  is independently selected from among —OR c2 , —NR c2 R c2 , halogen, —CN, —C(O)R c2 , —C(O)OR c2 , —C(O)NR c2 R c2 , —S(O) 2 R c2 , —S(O) 2 NR c2 R c2 , —NHC(O)R c2  and —N(C 1-4 alkyl)C(O)R c2 ; 
 each R c2  independently of one another denotes hydrogen or a group, optionally substituted by one or more, identical or different R d2  and/or R e2 , selected from among C 1-6 alkyl, C 2-6 alkenyl, C 2-6 alkynyl, C 1-6 haloalkyl, C 3-6 cycloalkyl, C 4-6 cycloalkenyl, C 6-10 aryl, 5-10 membered heteroaryl and 3-10 membered heterocyclyl; 
 each R d2  is independently selected from among —OR e2 , —NR e2 R e2 , halogen, —CN, —C(O)R e2 , —C(O)OR e2 , —C(O)NR e2 R e2 , —S(O) 2 R e2 , —S(O) 2 NR e2 R e2 , —NHC(O)R e2  and —N(C 1-4 alkyl)C(O)R e2 ; 
 each R e2  independently of one another denotes hydrogen or a group selected from among C 1-6 alkyl, C 2-6 alkenyl, C 2-6 alkynyl, C 1-6 haloalkyl, C 3-6 cycloalkyl, C 4-6 cycloalkenyl, C 6-10 aryl, 5-10 membered heteroaryl and 3-10 membered heterocyclyl; 
 
 A is selected from among phenyl and 5-6 membered heteroaryl; 
 each R 4  is independently selected from among R a4  and R b4 ;
 each R a4  independently of one another is a group, optionally substituted by one or more, identical or different R b4  and/or R c4 , selected from among C 1-6 alkyl, C 2-6 alkenyl, C 2-6 alkynyl, C 1-6 haloalkyl, C 3-7  cycloalkyl, C 4-7  cycloalkenyl, C 6-10  aryl, 5-10 membered heteroaryl and 3-10 membered heterocyclyl; 
 each R b4  is independently selected from among —OR c4 , —NR c4 R c4 , halogen, —CN, —C(O)R c4 , —C(O)OR c4 , —C(O)NR c4 R c4 , —C(O)NR c4 R c4 , —S(O) 2 R c4 , —S(O) 2 NR c4 R c4 , —NHSO 2 R c4 , —N(C 1-4 alkyl)SO 2 R c4 , —NHC(O)R c4  and —N(C 1-4 alkyl)C(O)R c4 ; 
 each R c4  independently of one another denotes hydrogen or a group, optionally substituted by one or more, identical or different R d4  and/or R e4 , selected from among C 1-6 alkyl, C 2-6 alkenyl, C 2-6 alkynyl, C 1-6 haloalkyl, C 3-7 cycloalkyl, C 4-7 cycloalkenyl, C 6-10 aryl, 5-10 membered heteroaryl and 3-10 membered heterocyclyl; 
 each R d4  is independently selected from among —OR e4 , —NR e4 R e4 , halogen, —CN, —C(O)R e4 , —C(O)OR e4 , —C(O) NR e4 R e4 , —C(O)NR g4 OR e4 , —S(O) 2 R e4 , —S(O) 2 NR e4 R e4 , —NHC(O)R e4  and —N(C 1-4 alkyl)C(O)R e4 ; 
 each R e4  independently of one another denotes hydrogen or a group, optionally substituted by one or more, identical or different R f4  and/or R g4 , selected from among C 1-6 alkyl, C 2-6 alkenyl, C 2-6 alkynyl, C 1-6 haloalkyl, C 3-7 cycloalkyl, C 4-7 cycloalkenyl, C 6-10 aryl, 5-10 membered heteroaryl and 3-10 membered heterocyclyl; 
 each R f4  is independently selected from among —OR g4 , —NR g4 R g4 , halogen, —CN, —C(O)R g4 , —C(O)OR g4 , —C(O)NR g4 R g4 , —C(O)NR g4 OR g4 , —S(O) 2 R g4 , —S(O) 2 NR g4 R g4 , —NHC(O)R g4  and —N(C 1-4 alkyl)C(O)R g4 ; 
 each R g4  is independently selected from among hydrogen, C 1-6 alkyl, C 2-6 alkenyl, C 2-6  alkynyl, C 1-6 haloalkyl, C 3-7 cycloalkyl, C 4-7 cycloalkenyl, C 6-10 aryl, 5-10 membered heteroaryl and 3-10 membered heterocyclyl; 
 
 r denotes the number 0, 1, 2 or 3 
 R 5  and R 6 , each independently, is selected from among hydrogen, C 1-4 alkyl and C 1-4 haloalkyl; 
 n denotes the number 0 or 1; 
 each R 7  is independently selected from among halogen, C 1-4 alkyl, —CN, C 1-4 haloalkyl, —OC 1-4 alkyl and —OC 1-4 haloalkyl; 
 q denotes the number 0, 1, 2 or 3; 
 W, X and Y is each independently selected from —N═ and —CH═ 
 with the proviso that the hydrogen in each —CH═ may be replaced by a substituent R 7  if present and that a maximum of two of W, X and Y can be —N═; 
 V is oxygen or sulfur; 
 or a salt thereof. 
 
     
     
         3 . A method for synthesizing the synthetic intermediate A-4 according to  claim 1 : 
       
         
           
           
               
               
           
         
         comprising reacting a compound A-1 
       
       
         
           
           
               
               
           
         
         with an amino alcohol A-2* 
       
       
         
           
           
               
               
           
         
         wherein R 2 , R 3 , R 5 , R 6 , R 7 , V, W, X, Y, n and q are defined as in  claim 1 .